Cover Image
Read Now

Drug class review on pharmacologic treatments for ADHD final report

According to the most recent NIH Consensus Statement (1998), "attention deficit hyperactivity disorder (ADHD) is the most commonly diagnosed childhood behavioral disorder." Historically, drug therapy of ADHD has consisted primarily of stimulant medications. More recently, nonstimulant medi...

Full description

Bibliographic Details
Main Authors: McDonagh, Marian S., Peterson, Kim (Author), Dana, Tracy (Author), Thakurta, Sujata (Author)
Corporate Authors: Oregon Health & Science University Evidence-based Practice Center, Oregon Health & Science University, Drug Effectiveness Review Project
Format: eBook
Language:English
Published: Portland, Oregon Oregon Health & Science University 2007, 2007
Edition:Final report update 2
Series:Drug class reviews
Subjects:
Attention Deficit Disorder With Hyperactivity / Drug Therapy
Comparative Effectiveness Research
Propylamines / Therapeutic Use
Treatment Outcome
Central Nervous System Stimulants / Therapeutic Use
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:According to the most recent NIH Consensus Statement (1998), "attention deficit hyperactivity disorder (ADHD) is the most commonly diagnosed childhood behavioral disorder." Historically, drug therapy of ADHD has consisted primarily of stimulant medications. More recently, nonstimulant medication treatment alternatives have been identified. The purpose of this review is to compare the benefits and harms of different pharmacologic treatments for ADHD in children and adults
Item Description:Title from PDF t.p. - "December 2007.". - Succeeded by Pharmacologic treatments for attention deficit hyperactivity disorder / Marian S. McDonagh, Vivian Christensen, Kim Peterson, Sujata Thakurta ; Drug Effectiveness Review Project, Oregon Evidence-based. Final report update 3. 2009
Physical Description:1 PDF file (132 pages) illustrations

Similar Items